Mechanistically, CXCL10 from the stroma activates CXCR3 on tumor cells and stimulates downstream signaling pathways such as MAPK/ERK and PI3K/Akt, leading to cytoskeletal reorganization, enhanced cell survival and targeted migration. The gene discussed is AKT1; the disease is neoplasm.